Skip to main content
NUTRITION 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Clinical and Translational Nutrition

Session: Design and Implementation of a Large Multicenter Nutrition Intervention Study: Lessons Learned from the Habitual Diet and Avocado Trial (Sponsored Satellite Program)

Panel Insights & Discussion with HAT Investigators (Sponsored Satellite Program)

Sunday, July 23, 2023
6:35 AM – 7:30 AM ET
Location:  Back Bay B-D

Sponsored by Hass Avocado Board

    Speaker(s)

  • Zhaoping Li, MD, PhD

    Professor
    Center for Human Nutrition, David Geffen School of Medicine at UCLA
    Los Angeles, California, United States

    Disclosure(s): WiseCode Nutrition Institute: Advisory Committee/Board Member (Ongoing)

  • Joan Sabaté, MD, DrPH

    Professor of Nutrition
    Nutrition, Loma Linda University School of Public Health Center for Nutrition
    Loma Linda, California, United States

    Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

  • AL

    Alice H. Lichtenstein, DSc (she/her/hers)

    Gershoff Professor of Nutrition Science and Policy Director, Cardiovascular Nutrition Laboratory and Senior Scientist
    JM USDA Human Nutrition Research Center on Aging, Tufts University
    Boston, Massachusetts, United States

    Disclosure(s): Hass avocado Board: Grant/Research Support (Terminated)

  • Penny M. Kris-Etherton, PhD (she/her/hers)

    Evan Pugh University Professor of Nutritional Sciences
    The Pennsylvania State University
    University Park, Pennsylvania, United States

    Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Disclosure(s):
Zhaoping Li, MD, PhD: WiseCode Nutrition Institute: Advisory Committee/Board Member (Ongoing)
Joan Sabaté, MD, DrPH: No relevant financial relationship(s) with ineligible companies to disclose.
Alice H. Lichtenstein, DSc: Hass avocado Board: Grant/Research Support (Terminated)
Penny M. Kris-Etherton, PhD: No relevant financial relationship(s) with ineligible companies to disclose.